跳至主要内容
临床试验/NCT05088499
NCT05088499已完成不适用

Preventive and Personalized Medicine (2021-2023)

Asfendiyarov Kazakh National Medical University1 个研究点 分布在 1 个国家目标入组 600 人开始时间: 2022年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
600
试验地点
1
主要终点
number of SNPs associated with epilepsy

研究概览

简要总结

This is a GWAS study that aims to identify possible candidate genes associate to epilepsy by exploring single nucleotide polymorphism (SNP) in a group of epilepsy, in the Kazakh population. The investigators hypothesize that the careful phenotyping of the subject sand matching with increase the power to find SNP significantly associate with epilepsy

详细描述

A genome-wide association study (GWAS) is an approach used in genetics research to associate specific genetic variations with particular diseases. The method involves scanning the genomes from many different people and looking for genetic markers that can be used to predict the presence of a disease. Once such genetic markers are identified, they can be used to understand how genes contribute to the disease and develop better prevention and treatment strategies

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
0 Years 至 5 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Children with seizures, confirmed by EEG and no morphological damage to the brain, confirmed by MRI of the brain;
  • The age of the patients is from 0 to 5 years;
  • Persons of Kazakh nationality, whose paternal and maternal grandparents are Kazakhs;
  • Children are parents or legal guardians who have given written informed consent.

排除标准

  • Children over 5 years old;
  • Children whose parents, according to the researcher, are mentally or legally incapacitated, which prevents obtaining informed consent;
  • Children with seizures with brain damage that cause epilepsy;
  • Children of a non-Kazakh ethnic group.

结局指标

主要结局

number of SNPs associated with epilepsy

时间窗: 1 year

Using GWAS to identify candidate genes associate with epilepsy

次要结局

未报告次要终点

研究者

发起方
Asfendiyarov Kazakh National Medical University
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ildar Fakhradiyev

Head of the Laboratory of Experimental Medicine

Asfendiyarov Kazakh National Medical University

研究点 (1)

Loading locations...

相似试验